LittéRéalité, vol. XVII, n° 2 (automne/hiver 2005), 120 p.

Cover vol.2, no.2 October 2005

Xvii Ibc 2005

Persian-translation vol.2, no.2 October 2005

Cancer Immunity, Vol. 5, p. 6 (22 March 2005)

There is considerable interest in developing immunotherapeutic approaches to elicit tumor-specific CTL responses in cancer patients. Epitope-based approaches aim to deliver the antigenic peptides or epitopes recognized by CTLs rather than the intact tumor antigen. Many tumor-associated proteins are nonmutated self proteins for which the dominant peptide epitopes are usually poorly immunogenic. ...

Cancer Immunity, Vol. 5, p. 9 (7 July 2005)

Transcripts with ESTs derived exclusively or predominantly from testis, and not from other normal tissues, are likely to be products of genes with testis-restricted expression, and are thus potential cancer/ testis (CT) antigen genes. A list of 371 genes with such characteristics was compiled by analyzing publicly available EST databases. RT-PCR analysis of normal and tumor tissues was performe...